The dollar index (DXY00 ) tumbled to a 5-week low on Wednesday and finished down by -0.32%. The dollar sank Wednesday after Democrats swept Congress in the US midterm elections, fueling concerns about political gridlock and tougher tech regulation that could curtail foreign demand for US assets. Wednesday’s -8% plunge...
Investigators are just beginning the lengthy process of determining why a business jet plummeted from the sky in Florida after encountering a thunderstorm and slammed into the ground with such force that it created a crater and shattered the plane.
Nick Wright, Chris Broussard, Kevin Wildes, and Danny Parkins analyze some cool stats entering Week 9, including the Minnesota Vikings needing better performances from their offense, Jaxon Smith-Njigba and the Seattle Seahawks needing some help, a...
As of early evening on Nov. 4, Bitcoin (CRYPTO:BTC) rose 3.64% to $80,156.15, Ethereum (CRYPTO:ETH) rose 6.58% to $2,421.50, and Solana (CRYPTO:SOL) rose 2.19% to $94.94.
ScottsMiracle-Gro shares rose about 10% after its earnings report, with investors focusing on guidance that exceeded expectations. Nate Baxter, the company’s President and CEO, says fiscal 2026 revenue grew about 1%, partly because the company exited lower-margin commodity products and changed its product mix. He speaks with Romaine Bostick & Vonnie Quinn on "The Close." (Source: Bloomberg)
CollPlant Biotechnologies Ltd. announced that its Board of Directors has approved a proposal to change the Company’s name to OptiPhi Computing Ltd., subject to shareholders approval and completion of the applicable corporate and regulatory procedures. The proposed name refl
Central Puerto S.A. announced that the Company and Proener S.A.U., a wholly owned subsidiary of the Company, have acquired treasury shares issued by the Company. The acquisitions were made pursuant to the terms of Article 64 et seq. of Capital Markets Law No. 26,831 and the regul
Galapagos NV announced the acceptance of a poster presentation at the 2026 American Society of Hematology Annual Meeting, scheduled for December 12-15, featuring preliminary data for gamgertamig in relapsed/refractory autoimmune cytopenias. Gamgertamig is an investigational BCMAx